Herve Meudal

Mr. Herve Meudal

Plateforme MO2VING-RMN, Centre de Biophysique Moléculaire, Orléans, Centre-Val de Loire, France
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2008 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
TCThomas Chauvin
Thomas Chauvin
PDPhilippe Durand
Philippe Durand
MBMichèle Bernier
Michèle Bernier
HMHerve Meudal
Herve Meudal
BDBich‐Thuy Doan
Bich‐Thuy Doan
ÉTÉva Tóth
Éva Tóth

7 October 2022 in Science Advances
Verified
Journal Article
Open access
KZKang Zhu
Kang Zhu
MSMarcin J. Suskiewicz
Marcin J. Suskiewicz
AHAndrea Hloušek-Kasun
Andrea Hloušek-Kasun
HMHerve Meudal
Herve Meudal
AMAndreja Mikoč
Andreja Mikoč
IAIvan Ahel
Ivan Ahel
Ubiquitylation had been considered limited to protein lysine residues, but other substrates have recently emerged. Here, we show that DELTEX E3 ligases specifically target the 3′ hydroxyl of the adenosine diphosphate (ADP)–ribosyl moiety that can be linked to a protein, thus generating a hybrid ADP-ribosyl-ubiquitin modification. Unlike other known hydroxyl-specific E3s, which proceed via a covalent E3~ubiqutin intermediate, DELTEX enzymes are RING E3s that stimulate a direct ubiquitin transfer from E2~ubiquitin onto a substrate. However, DELTEXes follow a previously unidentified paradigm for RING E3s, whereby the ligase not only forms a scaffold but also provides catalytic residues to activate the acceptor. Comparative analysis of known hydroxyl-ubiquitylating active sites points to the recurring use of a catalytic histidine residue, which, in DELTEX E3s, is potentiated by a glutamate in a catalytic triad-like manner. In addition, we determined the hydrolase specificity profile of this modification, identifying human and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enzymes that could reverse it in cells.

1 November 1997 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BBBruno Bellier
Bruno Bellier
IMIsabelle McCort
Isabelle McCort
BDBertrand Ducos
Bertrand Ducos
SDSophie Danascimento
Sophie Danascimento
HMHerve Meudal
Herve Meudal
BRBernard P. Roques
Bernard P. Roques

15 March 2000 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HCHuixiong Chen
Huixiong Chen
FNFlorence Noble
Florence Noble
AMAurélie Mothé
Aurélie Mothé
HMHerve Meudal
Herve Meudal
PCPascale Coric
Pascale Coric
MFMarie-Claude Fournié-Zaluski
Marie-Claude Fournié-Zaluski

23 November 1999 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CDChristelle David
Christelle David
LBLaurent Bischoff
Laurent Bischoff
HMHerve Meudal
Herve Meudal
AMAurélie Mothé
Aurélie Mothé
NMNadia De Mota
Nadia De Mota
BRBernard P. Roques
Bernard P. Roques

1 January 1996 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MFMarie-Claude Fournie-Zaluski
Marie-Claude Fournie-Zaluski
PCPascale Coric
Pascale Coric
VTVincent Thery
Vincent Thery
WGWalter Gonzalez
Walter Gonzalez
HMHerve Meudal
Herve Meudal
BRBernard P. Roques
Bernard P. Roques